Related Experiment Video
Updated: Aug 3, 2025

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
Published on: April 6, 2022
Gut Microbiota Dysbiosis in Suspected Food Protein Induced Proctocolitis-A Prospective Comparative Cohort Trial
Philipp Wurm1, Laura Stampfer2, Theresa Greimel2
1From Institute of Pathology, Medical University of Graz, Graz, Austria.
Insights
Infants with suspected food protein-induced proctocolitis (sFPIP) show gut microbiota dysbiosis. Diagnostic dietary intervention (DDI) normalizes gut bacteria, suggesting dysbiosis may cause sFPIP symptoms like hematochezia.
Area of Science:
- Microbiome research
- Pediatric gastroenterology
- Immunology
Background:
- Suspected food protein-induced proctocolitis (sFPIP) diagnosis is challenging, with many infants not confirmed after diagnostic dietary intervention (DDI).
- Hematochezia in infants with sFPIP lacks a clear pathophysiological explanation.
- Understanding the gut microbiome's role in sFPIP is crucial for accurate diagnosis and management.
Purpose of the Study:
- To investigate the gut microbiota composition in infants with sFPIP compared to healthy controls.
- To determine if DDI alters the gut microbiota in infants with sFPIP.
- To explore the potential link between gut dysbiosis and hematochezia in sFPIP.
Main Methods:
- Prospective study comparing sFPIP infants and healthy controls.
- 16S rRNA and shotgun metagenomic sequencing of fecal samples.
- Analysis of microbial composition using Qiime2, DADA2, KneadData, and MetaPhlAn2.
Main Results:
- sFPIP infants exhibited significant differences in gut microbial composition compared to controls at baseline.
- Healthy infants showed higher abundance of Bifidobacterium, while sFPIP infants had increased Clostridium sensu stricto 1.
- DDI led to a sustained increase in Bifidobacterium in sFPIP infants, normalizing their microbiota.
Conclusions:
- Gut microbiota dysbiosis is a key feature in infants with sFPIP.
- DDI effectively modulates the gut microbiota towards a healthy composition in sFPIP infants.
- Gut dysbiosis is a likely trigger for hematochezia in the majority of sFPIP infants.
Objectives:
In infants with suspected food protein induced proctocolitis (sFPIP) only a minority of patients are finally diagnosed with the disease following diagnostic dietary intervention (DDI). There is a need for a pathophysiological explanation for the cause of hematochezia in the majority of sFPIP infants.
Methods:
We prospectively recruited infants with sFPIP and healthy controls. Fecal samples were collected at inclusion, week 4 (end of DDI in sFPIP), and week 8. For 16S rRNA sequencing (515F/806R) we used Illumina MiSeq sequencing system. Amplicon sequence variants were generated using Qiime2 and DADA2. Qiime diversity alpha and beta group comparisons and linear discriminant analysis effect size analysis was performed. For shotgun metagenomic analysis on species level we used KneadData and MetaPhlAn2.
Results:
Fourteen sFPIP infants were compared to 55 healthy infants. At inclusion overall microbial composition of sFPIP infants differed significantly from controls (weighted UniFrac; Pairwise PERMANOVA, P = 0.002, pseudo- F = 5.008). On genus level healthy infant microbiota was significantly enriched with Bifidobacterium ( B ) compared to sFPIP patients (linear discriminant analysis [LDA] = 5.5, P < 0.001, 31.3% vs 12.1%). sFPIP stool was significantly enriched by Clostridium sensu stricto 1 over controls (LDA = 5.3, P = 0.003, 3.5% vs 18.3%). DDI caused a significant and sustained increase of Bifidobacterium (LDA = 5.4, P = 0.048, 27.9%) in sFPIP infants. Species level analysis revealed significant reduction of abundance of B longum in sFPIP patients, which after DDI was reversed by B. species other than B longum .
Conclusions:
We revealed a gut microbiota dysbiosis phenomenon in sFPIP infants. DDI induces a microbiota composition comparable to that of healthy infants. In most sFPIP infants hematochezia might be triggered by a gut microbiota dysbiosis phenomenon.
More Related Videos
08:24Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
08:53Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
Published on: July 27, 2022
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...